Hotchkis & Wiley Capital Management
USNA icon

Hotchkis & Wiley Capital Management’s Usana Health Sciences USNA Stock Holding History

Hotchkis & Wiley Capital Management’s Portfolio USNA Stock Details USNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-117,620
Closed -$6.3M – 527
2023
Q4 		$6.3M Buy
117,620
+26,450
+29% +$1.34M 0.02% 365
2023
Q3 		$5.34M Sell
91,170
-24,350
-21% -$1.52M 0.02% 355
2023
Q2 		$7.28M Sell
115,520
-2,510
-2% -$160K 0.03% 291
2023
Q1 		$7.42M Buy
118,030
+4,700
+4% +$280K 0.03% 249
2022
Q4 		$6.03M Buy
113,330
+43,410
+62% +$2.35M 0.02% 291
2022
Q3 		$3.92M Sell
69,920
-28,190
-29% -$1.86M 0.02% 369
2022
Q2 		$7.1M Buy
98,110
+11,340
+13% +$844K 0.03% 237
2022
Q1 		$6.89M Buy
86,770
+15,528
+22% +$1.4M 0.02% 293
2021
Q4 		$7.21M Sell
71,242
-2,600
-4% -$259K 0.02% 260
2021
Q3 		$6.81M Buy
73,842
+4,880
+7% +$470K 0.02% 256
2021
Q2 		$7.06M Buy
68,962
+3,400
+5% +$341K 0.02% 255
2021
Q1 		$6.4M Sell
65,562
-2,398
-4% -$218K 0.02% 266
2020
Q4 		$5.24M Buy
67,960
+34,540
+103% +$2.67M 0.02% 259
2020
Q3 		$2.46M Sell
33,420
-23,750
-42% -$1.91M 0.01% 339
2020
Q2 		$4.2M Sell
57,170
-19,310
-25% -$1.51M 0.02% 235
2020
Q1 		$4.42M Sell
76,480
-17,520
-19% -$1.22M 0.02% 162
2019
Q4 		$7.38M Buy
94,000
+8,510
+10% +$627K 0.03% 157
2019
Q3 		$5.85M Buy
85,490
+14,660
+21% +$984K 0.02% 163
2019
Q2 		$5.63M Buy
+70,830
New +$5.62M 0.02% 193
2018
Q2 		– Sell
-12,312
Closed -$1.06M – 531
2018
Q1 		$1.06M Hold
12,312
– – ﹤0.01% 315
2017
Q4 		$912K Buy
+12,312
New +$824K ﹤0.01% 320

Other funds holding USNA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Pzena Investment Management
Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Hotchkis & Wiley Capital Management's USNA Position: Q1 2024 in Review

Hotchkis & Wiley Capital Management sold out of Usana Health Sciences (USNA) in Q1 2024, closing a stake of 117,620 shares — an estimated $6.3M sold.

Hotchkis & Wiley Capital Management first reported a position in USNA in Q4 2017 and held it in 21 quarters. The position peaked at $7.42M in Q1 2023. 161 funds tracked by Wall St. Rank hold USNA as of Q1 2024.

  • Hotchkis & Wiley Capital Management reported no remaining Usana Health Sciences position as of Q1 2024 after selling out during the quarter.
  • Hotchkis & Wiley Capital Management sold 117,620 Usana Health Sciences shares in Q1 2024, an estimated $6.3M.
  • Hotchkis & Wiley Capital Management first reported a position in Usana Health Sciences in Q4 2017 and held it in 21 quarters.
  • Hotchkis & Wiley Capital Management's Usana Health Sciences position peaked at $7.42M in Q1 2023.
  • 161 funds tracked by Wall St. Rank held Usana Health Sciences as of Q1 2024.

Based on Hotchkis & Wiley Capital Management's 13F filing for Q1 2024, filed 14 May 2024.